Healthcare Services

Metabolic Testing Market Expected to Record Steady Growth and Approach $0.91 Billion by 2030

April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Metabolic Testing Market Projected To Become By 2030 Based On Its 2026 Valuation?

The metabolic testing market has experienced substantial growth in recent years. Its value is projected to climb from $0.64 billion in 2025 to $0.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. This past growth can be attributed to factors such as the increasing prevalence of obesity, the expanding use of indirect calorimetry, the greater integration of cpets in hospitals, the broadening scope of diagnostic applications, and an enhanced awareness of metabolic disorders.

The metabolic testing market is anticipated to show significant expansion in the coming years. It is projected to reach $0.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This expansion during the forecast period stems from factors such as the proliferation of personalized wellness programs, the increasing adoption of sports performance analytics, a surging demand for remote health monitoring, the broadening availability of wearable metabolic sensors, and the growing incorporation of AI-based diagnostic instruments. Key developments anticipated in this period encompass the widespread use of personalized metabolic health initiatives, AI-driven assessment and forecasting of metabolic rates, cloud-based data tracking solutions for metabolic tests, the mechanization of metabolic testing apparatus, and real-time IoT-powered body analytics.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21219&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Metabolic Testing Market?

The escalating occurrence of chronic illnesses is anticipated to propel the metabolic testing market in the future. These conditions are defined as enduring health issues that typically last for a year or longer, necessitating continuous medical oversight or restricting daily activities. The rise in chronic disease cases stems from unhealthy living habits, inadequate dietary choices, and an aging global demographic. Metabolic testing is vital for the effective management of chronic diseases; it offers significant understanding into an individual’s metabolic state, facilitating the prompt identification of conditions like diabetes, cardiovascular diseases, and metabolic syndrome. This insight aids in tailoring treatment strategies and enhancing overall disease control. For example, in September 2023, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, reported that 41 million deaths globally, representing 74% of all annual fatalities, were attributable to chronic diseases. This figure encompasses 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the growing incidence of chronic diseases will stimulate growth in the metabolic testing market.

What Segment Groups Are Identified Within The Metabolic Testing Market?

The metabolic testing market covered in this report is segmented –

1) By Equipment Type: Body Composition Analyzers, Cardiopulmonary Exercise Testing (CPET) Systems, Electrocardiogram Systems (ECG) Systems, Metabolic Carts, Other Equipment Types

2) By Technology: VO2 Max Analysis, RMR Analysis, Body Composition Analysis

3) By Application: Critical Care, Lifestyle Diseases, Other Applications

4) By End User: Hospitals And Clinics, Sports Training Centers, Other End Users

Subsegments:

1) By Body Composition Analyzers: Dual-Energy X-ray Absorptiometry (DXA), Bioelectrical Impedance Analysis (BIA), Air Displacement Plethysmography (ADP)

2) By Cardiopulmonary Exercise Testing (CPET) Systems: Treadmill Or Cycle Ergometer-based CPET, Oxygen Consumption Measurement Systems, Gas Exchange Measurement Systems

3) By Electrocardiogram (ECG) Systems: Resting ECG Systems, Stress ECG Systems, Holter Monitors

4) By Metabolic Carts: Indirect Calorimetry Metabolic Carts, Open-Circuit Spirometry Metabolic Carts

5) By Other Equipment Types: Continuous Glucose Monitoring Systems, Lactate Testing Devices, Blood Pressure Monitoring Devices

What Key Trends Are Influencing The Development Of The Metabolic Testing Market?

Major companies in the metabolic testing market are concentrating on developing innovative diagnostic equipment, such as metabolic analyzers, to improve real-time metabolic analysis and enhance research accuracy. A metabolic analyzer is a medical instrument used to gauge an individual’s metabolic rate and assess various metabolic functions. It evaluates how efficiently the body processes oxygen and converts food into energy, offering insights into calorie consumption, the utilization of fuel sources (carbohydrates versus fats), and respiratory efficiency. For instance, in September 2024, PHC Corporation, a Japan-based company specializing in healthcare solutions, launched LiCellMo, a live cell metabolic analyzer designed for the real-time visualization of cellular metabolism in cell and gene therapy research. The LiCellMo live cell metabolic analyzer provides unique functionalities like real-time, continuous, and non-invasive monitoring of glucose and lactate concentrations in cell cultures, offering a comprehensive understanding of cellular metabolism without disturbing the experiment. This enables researchers to observe metabolic changes in cell cultures, providing a more complete depiction of cell activity.

Which Companies Hold Significant Positions In The Metabolic Testing Market?

Major companies operating in the metabolic testing market are Becton Dickinson and Company, Lumen Technologies Inc., Laboratory Corporation of America Holdings LabCorp, Quest Diagnostics Incorporated, Agilent Technologies Inc., Vyaire Medical Inc., Microlife Medical Home Solutions Inc., MGC Diagnostics Corporation, Geratherm Medical AG, Actofit Wearables, COSMED Srl, Levels Health Inc, Cortex Biophysik GmbH, KORR Medical Technologies Inc., iWorx Systems Inc., General Electric Company GE Healthcare, Hologic Inc, Koninklijke Philips NV, Parvo Medics Inc, InBody Co Ltd, Schiller AG, Noraxon USA Inc, Seca GmbH Co KG

Read the full metabolic testing market report here:

https://www.thebusinessresearchcompany.com/report/metabolic-testing-global-market-report

Which Regions Are Projected To Dominate The Metabolic Testing Market In The Coming Years?

North America was the dominant region in the metabolic testing market in 2025. Asia-Pacific is expected to be the exponential growth region in the forecast period. The regions covered in the metabolic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Metabolic Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21219&type=smp

Browse Through More Reports Similar to the Global Metabolic Testing Market 2026, By The Business Research Company

Peptide Based Metabolic Disorders Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report

Insuman Global Market Report

https://www.thebusinessresearchcompany.com/report/insuman-global-market-report

Dumping Syndrome Global Market Report

https://www.thebusinessresearchcompany.com/report/dumping-syndrome-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795